Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET

Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask for the Applied DNA call; via webcast .

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, January 31, 2019
Information
Tags: 
Technology, Supply chain management, Security, Manufacturing, Chemicals, Plastics, Packaging, Textiles, Retail, Research, Other Science, Other Retail, Science, Genetics, Biology, Genotyping, Life sciences, Nature
Geotags: 
United States, NEW YORK
⚠generated by AI ↴
Summary
Key Points: 
  • Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask for the Applied DNA call; via webcast .
  • The webcast will be archived in under the IR Calendar portion of the Investors section of the companys website.
  • Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, personalized medicine and therapeutics.
  • The statements made by Applied DNA in this press release may be forward-looking in nature within the meaning of the Private Securities Litigation Act of 1995.


Applied
DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to
release financial results for its fiscal 2019 first quarter ended
December 31, 2018 after market close on Thursday, February 7, 2019. In
conjunction with the release, the Company has scheduled a conference
call at 4:30 p.m. Eastern Time that will also be broadcast live over the
Internet.

What:

      Applied DNA’s Fiscal 2019 First Quarter Financial Results Conference
Call

When:

Thursday, February 7, 2019, at 4:30 p.m. Eastern Time

Where:

Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask
for the Applied DNA call; via webcast.

A telephonic replay of the conference call will be available for one day
and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with
the passcode 10127851. The webcast
will be archived in under the IR Calendar portion of the Investors
section of the company’s website.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics, personalized
medicine and therapeutics.

Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion.

Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are
listed under the symbol APDNW.

Forward Looking Statements

The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe Applied
DNA’s future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to its history of net
losses, limited financial resources, limited market acceptance and
various other factors detailed from time to time in Applied DNA’s SEC
reports and filings, including our Annual Report on Form 10-K filed on
December 18, 2018 and other reports we file with the SEC, which are
available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.

Copyright: 
Copyright Business Wire 2019